EMILY MARIE GROSZEWSKI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AUSTIN, TX NPI 1548935968
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Novo Nordisk AS All categories
General Payments — all program years on this page
$1,818.77
- Category: General Payments
- Program years: PY2021–2024
- Record count: 46
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $231.86 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.86 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $56.64 | 2 |
| ABIOMED | $38.11 | 1 |
| Alnylam Pharmaceuticals Inc. | $33.47 | 1 |
| Amgen Inc. | $32.74 | 2 |
| Kiniksa Pharmaceuticals International, plc | $29.18 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.47 | 1 |
| PFIZER INC. | $18.25 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086948811 | Novartis Pharmaceuticals Corporation | $23.47 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100232666 | Novo Nordisk Inc | $29.48 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100599627 | Novo Nordisk Inc | $27.16 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115682492 | Amgen Inc. | $16.65 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115682500 | Amgen Inc. | $16.09 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125842871 | Alnylam Pharmaceuticals Inc. | $33.47 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130942057 | PFIZER INC. | $18.25 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142259154 | ABIOMED | $38.11 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154855581 | Kiniksa Pharmaceuticals International, plc | $29.18 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.